Millstone Evans Group, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Millstone Evans Group, LLC

$147 Billion
Q4 2024

A detailed history of Millstone Evans Group, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Millstone Evans Group, LLC holds 55 shares of XBI stock, worth $5,018. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$5,018

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 11, 2025	BUY	$89.81 - $104.0 $4,939 - $5,720	55 New	55 $4.95 Million

Others Institutions Holding XBI

# of Institutions

915

Shares Held

99.3M

Call Options Held

28.4M

Put Options Held

34.5M

Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.12 Billion
0.1% of portfolio
Goldman Sachs Group Inc New York, NY

9.56M
Shares

$872 Million
0.14% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$842 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$732 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$707 Million
0.45% of portfolio

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millstone Evans Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millstone Evans Group, LLC with notifications on news.

Account

Millstone Evans Group, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History